ArticleInfectious diseases and therapy2023

Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia.

Shun Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.